POOLED SAFETY ANALYSIS OF TEN CLINICAL STUDIES EVALUATING FIXED-DOSE ORAL TESTOSTERONE UNDECANOATE IN MALE PATIENTS WITH TESTOSTERONE DEFICIENCY

被引:0
|
作者
Khera, M. [1 ]
Miner, M. [2 ]
Goldstein, I. [3 ]
Goldstein, R. [4 ]
Chidambaram, N. [5 ]
Delconte, A. [5 ]
Dobs, A. [6 ]
机构
[1] Baylor Coll Med, Houston, TX USA
[2] Brown Univ, Providence, RI USA
[3] Univ Calif San Diego, San Diego, CA USA
[4] Halozyme, San Diego, CA USA
[5] Lipocine Inc, Salt Lake City, UT USA
[6] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
393
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies
    Chervinsky, P.
    Meltzer, E. O.
    Busse, W.
    Ohta, K.
    Bardin, P.
    Bredenbroeker, D.
    Bateman, E. D.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 : S28 - S34
  • [22] PROSTATE SAFETY OF TESTOSTERONE REPLACEMENT THERAPY IN MALE HYPOGONADISM: INTERIM RESULTS FROM THE LARGEST INTERNATIONAL TRIAL ON INJECTABLE LONG-ACTING TESTOSTERONE UNDECANOATE INVOLVING 763 PATIENTS
    Zitzmann, M.
    Hanisch, J. U.
    Mattern, A.
    Jungwirth, A.
    Maagi, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 56 - 57
  • [23] Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety
    Honig, Stanton
    Gittelman, Marc
    Kaminetsky, Jed
    Wang, Christina
    Amory, John K.
    Rohowsky, Nestor
    Dudley, Robert E.
    Seo, B. Woun
    Newmark, Jay
    Swerdloff, Ronald
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (12): : 1750 - 1758
  • [24] Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD
    Singh, Dave
    D'Urzo, Anthony D.
    Donohue, James F.
    Chuecos, Ferran
    Leselbaum, Anne
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In A Pooled Population Of Patients With COPD, Stratified By Age
    Mroz, R. M.
    Scanlon, P.
    Donohue, J. F.
    Molins, E.
    Lakkis, H.
    De Miquel, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
    Wedzicha, Jadwiga A.
    Dahl, Ronald
    Buhl, Roland
    Schubert-Tennigkeit, Agnes
    Chen, Hungta
    D'Andrea, Peter
    Fogel, Robert
    Banerji, Donald
    RESPIRATORY MEDICINE, 2014, 108 (10) : 1498 - 1507
  • [27] Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study
    Bouloux, Pierre M. G.
    Legros, Jean-Jacques
    Elbers, Jolanda M. H.
    Geurts, T. B. Paul
    Kaspers, Marion J. G. H.
    Meehan, Alan G.
    Meuleman, Eric J. H.
    AGING MALE, 2013, 16 (02): : 38 - 47
  • [28] An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug
    Bakshi, R
    Hermeling-Fritz, I
    Gathmann, I
    Alteri, E
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (04) : 419 - 424
  • [29] INTRA MUSCULAR TESTOSTERONE UNDECANOATE (TU) (NEBIDO®) AS TESTOSTERONE REPLACEMENT THERAPY (TRT) FOR ANDROGEN DEFICIENCY IN THE AGING MALE (ADAM) AND DIABETES MELLITUS TYPE 2 (DM2) PATIENTS: BRAZILIAN ECONOMIC MODELING
    Silva, A. P.
    Santoni, N. B.
    Pepe, C.
    Paladini, L.
    VALUE IN HEALTH, 2011, 14 (07) : A402 - A402
  • [30] Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats
    Misro, Man M.
    Chaki, Shankar P.
    Kaushik, Mahesh C.
    Nandan, Deoki
    CONTRACEPTION, 2009, 79 (06) : 488 - 497